Jump to ContentJump to Main Navigation

Online

149,00 € / $224.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
September 2011
ISSN:
2191-0251
DOI:
10.1515/JPEM.2011.241

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 149.00
RRP for USA, Canada, Mexico
US$ 224.00 *
Print
Individual Subscription Online only
Euro [D] 873.00
RRP for USA, Canada, Mexico
US$ 1310.00 *
Print + Online
Individual Subscription Online only
Euro [D] 1048.00
RRP for USA, Canada, Mexico
US$ 1572.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Editor-in-Chief: Zadik, Zvi

Editorial Board Member: Cassorla, Fernando / Cutfield, Wayne / de Muinck Keizer-Schrama, Sabine M.P.F. / Fideleff, Hugo L. / LaFranch, Stephen H. / Lanes M. D., Roberto / Levitsky, Lynne / Lippe, Barbara / Pfäffle, Roland / Root, Allen W. / Rosenfeld, Ron G. / Werther, George / Kiess, Wieland

12 Issues per year

IMPACT FACTOR 2011: 0.875
5-year IMPACT FACTOR: 1.026

VolumeIssuePage

Issues

Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents

1 / Laura Gruñeiro-Papendieck1 / Marcela Venara1 / Oscar Acha2 / Silvana Maglio3 / Ignacio Bergadá1 / Ana Chiesa1

1Endocrinology Division, Centro de Investigaciones Endocrinológicas (CEDIE), Ricardo Gutiérrez Children’s Hospital, Buenos Aires, Argentina

2Surgery Department, Ricardo Gutiérrez Children’s Hospital, Buenos Aires, Argentina

3Pathology Department, Ricardo Gutiérrez Children’s Hospital, Buenos Aires, Argentina

Corresponding author. Patricia Papendieck MD, Gallo 1360 1425 Buenos Aries, Argentina Phone: +541149635931, Fax: +0541149635930

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 24, Issue 9-10, Pages 743–748, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/JPEM.2011.241, September 2011

Publication History:
Received:
2011-04-01
Accepted:
2011-07-29
Published Online:
2011-09-20

Abstract

To review our Pediatric Endocrinology Division’s experience with differentiated thyroid carcinoma (DTC) we analyzed retrospectively the records of patients with DTC that had been seen between June 1988 and June 2008.

Results: Forty-five patients (median age 13.7 years, 36 female) were diagnosed (papillary: 40, follicular: 5) with DTC presenting as a solitary nodule (n: 25), thyroid nodule with cervical adenopathy (n: 9) and multinodular goiter (n: 11). All underwent total thyroidectomy with resection of suspicious cervical lymph nodes (CLN). DTC was multicentric in 59% and revealed extrathyroidal extension in 44%. Initially, 44% had CLN metastases and 24% distant metastases. All patients underwent thyroid remnant ablation with 131I and suppressive treatment. Median follow-up was 5.1 years with a disease-free survival rate at 5 years of follow-up of 75%. Eleven percent presented recurrences.

Conclusion: Pediatric DTC has an aggressive behavior at presentation. Higher preoperative TSH levels were significantly associated with a more advanced disease at diagnosis. CLT was present concomitantly in a quarter of the patients and further studies are needed to establish differences in these patients’ outcome. Diagnostic approach, total thyroidectomy, 131I treatment and thyrotropin suppression allowed a good progression-free survival rate.

Keywords: adolescence; childhood; differentiated thyroid carcinoma; follicular carcinoma; follow-up papillary carcinoma; radioactive iodine; thyroidectomy; thyrotropin stimulating hormone

Comments (0)

Please log in or register to comment.